European Medicines Agency is to tighten up on advisers’ conflicts of interestBMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2388 (Published 28 March 2012) Cite this as: BMJ 2012;344:e2388
- Deborah Cohen
The European Medicines Agency is to further restrict experts with conflict of interests from participating in their scientific committees, an agency spokesperson said on 26 March.
The announcement comes as the European Parliament prepares to approve the agency’s budget amid concerns that it might be delayed again. Last year, the agency’s budget was held back because of problems with management of the agency and issues around conflicts of interest.
The Court of Auditors found the agency had a “lack of respect to, and frequent lack of, implementing procedures regarding the identification and management of conflicts of interest for its staff and experts.”
Although the agency already has procedures in place, new policies will place further restrictions on experts who might have a household member with …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial